Learn About Cystectomy

Who are the top Cystectomy Local Doctors?
AK
Dr. Ashish M. Kamat
Urology | General Surgery
Elite
Highly rated in
8
conditions
Urology
General Surgery

University of Texas System

Physicians Referral Service

1515 Holcombe Blvd 
Houston, TX 77030

Ashish Kamat is an Urologist and a General Surgeon in Houston, Texas. Dr. Kamat has been practicing medicine for over 28 years and is rated as an Elite doctor by MediFind in the treatment of Cystectomy. He is also highly rated in 8 other conditions, according to our data. His top areas of expertise are Bladder Cancer, Cystectomy, Muscle Invasive Bladder Cancer, and Urothelial Cancer. He is licensed to treat patients in Texas. Dr. Kamat is currently accepting new patients.

View Profile
RS
Dr. Robert S. Svatek
Urology | General Surgery
Elite
Highly rated in
7
conditions
Urology
General Surgery

CHRISTUS Southeast Texas

Surgery Center - Robert B. Green Campus

903 W Martin St 
San Antonio, TX 78207

Robert Svatek is an Urologist and a General Surgeon in San Antonio, Texas. Dr. Svatek has been practicing medicine for over 20 years and is rated as an Elite doctor by MediFind in the treatment of Cystectomy. He is also highly rated in 7 other conditions, according to our data. His top areas of expertise are Bladder Cancer, Urothelial Cancer, Cystectomy, and Muscle Invasive Bladder Cancer. He is licensed to treat patients in Texas. Dr. Svatek is currently accepting new patients.

View Profile
 
 
 
 
Learn about our expert tiers
Learn more
SD
Dr. Siamak Daneshmand
Urology
Elite
Highly rated in
32
conditions
Urology

Keck Medicine of USC

Beverly Hills - Urology

9033 Wilshire Blvd 
Beverly Hills, CA 90211

Siamak Daneshmand is an Urologist in Beverly Hills, California. Dr. Daneshmand has been practicing medicine for over 26 years and is rated as an Elite doctor by MediFind in the treatment of Cystectomy. He is also highly rated in 32 other conditions, according to our data. His top areas of expertise are Bladder Cancer, Cystectomy, Urothelial Cancer, and Muscle Invasive Bladder Cancer. He is licensed to treat patients in California. Dr. Daneshmand is currently accepting new patients.

View Profile
View All Doctors
What are the Latest Advances for Cystectomy?
Effect of Robot-Assisted Radical Cystectomy With Intracorporeal Urinary Diversion vs Open Radical Cystectomy on 90-Day Morbidity and Mortality Among Patients With Bladder Cancer: A Randomized Clinical Trial.
Condition: Bladder Cancer
Journal: JAMA
Treatment Used: Robot-Assisted Radical Cystectomy with Intracorporeal Urinary Diversion vs. Open Radical Cystectomy
Number of Patients: 338
Published: May 15, 2022
View publication
Summary: Effect of Robot-Assisted Radical Cystectomy With Intracorporeal Urinary Diversion vs Open Radical Cystectomy on 90-Day Morbidity and Mortality Among Patients With Bladder Cancer: A Randomized Clinical Trial.
Impact of salvage cytotoxic chemotherapy on prognosis in patients with recurrence after radical cystectomy: a multi-institutional retrospective study.
Condition: Bladder Cancer with Recurrence After Radical Cystectomy (RC)
Journal: BMC urology
Treatment Used: Salvage Cytotoxic Chemotherapy (SC)
Number of Patients: 86
Published: May 13, 2022
View publication
Summary: Impact of salvage cytotoxic chemotherapy on prognosis in patients with recurrence after radical cystectomy: a multi-institutional retrospective study.
Tired of the same old research?
Check Latest Advances
Association of Open vs Robot-Assisted Radical Cystectomy With Mortality and Perioperative Outcomes Among Patients With Bladder Cancer in Sweden.
Condition: Bladder Cancer
Journal: JAMA network open
Treatment Used: Open versus Robot-Assisted Radical Cystectomy
Number of Patients: 3169
Published: April 28, 2022
View publication
Summary: Association of Open vs Robot-Assisted Radical Cystectomy With Mortality and Perioperative Outcomes Among Patients With Bladder Cancer in Sweden.
View All Latest Advances
What are the latest Cystectomy Clinical Trials?
Phase Ib Feasibility Trial of Neoadjuvant Nivolumab/Lirilumab in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer
Who is this study for: Adult patients with Muscle Invasive Bladder Cancer
Status: Active, not recruiting
Start Date: March 22, 2019
Intervention Type: Drug
Study Drugs: Nivolumab, Cisplatin
Phase: Phase 1
View Trial
Summary: Patients with muscle-invasive bladder cancer (MIBC) who can not receive cisplatin or refuse cisplatin therapy will receive nivolumab or nivolumab/lirilumab before a planned surgical procedure called a radical cystectomy (RC) to remove the bladder.~Nivolumab works by attaching to and blocking a molecule called Programmed Death-1 (PD-1). Lirilumab attaches to and blocks a group of molecules called K...
Match to trials
Find the right clinical trials for you in under a minute
Get started
A Prospective, Single Arm, Multicenter, Phase II-Trial to Assess Safety and Efficacy of Preoperative RAdiation Therapy Before Radical CystEctomy Combined With ImmunoTherapy in Locally Advanced Urothelial Carcinoma of the Bladder
Who is this study for: Patients with locally advanced urothelial carcinoma of the bladder
Status: Active, not recruiting
Start Date: February 4, 2019
Intervention Type: Drug, Procedure, Radiation
Study Drugs: Nivolumab
Phase: Phase 2
View Trial
Summary: A prospective, single arm, multicenter, Phase II-Trial to assess safety and efficacy of preoperative Radiation therapy before radical CystEctomy combined with ImmunoTherapy in locally advanced urothelial carcinoma of the bladder
View All Clinical Trials